You are here

Novo Nordisk

Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4

Fierce Pharma

Thu, 02/22/24 - 11:12 pm

Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing

Fierce Pharma

Wed, 02/21/24 - 11:25 am

Bristol Myers Squibb

Inflation Reduction Act

Actually Wegovy is good for dialysis companies, dialysis provider says

Stat

Wed, 02/21/24 - 11:12 am

Fresenius Medical Care

Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023

BioSpace

Tue, 02/20/24 - 05:55 pm

Novo Nordisk and Catalent deal: net positive or negative for industry?

Biopharma Reporter

Tue, 02/20/24 - 11:06 am

Wegovy fuels sharp rise in use of weight-loss drugs for US youth

Reuters

Thu, 02/15/24 - 07:24 pm

Weight loss drugs like Ozempic have food CEOs so 'scared' they're calling Novo Nordisk for advice

Quartz

Thu, 02/15/24 - 07:20 pm

Lars Fruergaard Jorgensen

3 questions hanging over the Novo-Catalent deal

Pharma Voice

Wed, 02/14/24 - 10:55 am

drug manufacturing

Novo Nordisk's controlling shareholder plans to invest about $35 bln by 2030

Reuters

Mon, 02/12/24 - 11:19 pm

Weight-loss drugs tied to benefit after hip replacement

Reuters

Mon, 02/12/24 - 10:26 am

hip replacements

COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings

BioSpace

Sun, 02/11/24 - 03:50 pm

Bristol Myers Squibb

As Catalent prepares to join Novo family, CDMO's sales continue to slide

Fierce Pharma

Fri, 02/9/24 - 11:21 am

New weight-loss drugs linked to lower risk of depression: study

Axios

Fri, 02/9/24 - 11:12 am

Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month

Motley Fool

Thu, 02/8/24 - 10:01 pm

Novo Nordisk CEO Jørgensen nets a 13% raise for 2023 amid soaring demand for Wegovy, Ozempic

Fierce Pharma

Wed, 02/7/24 - 09:15 pm

Lars Fruergaard Jorgensen

FDA finds control lapses at Catalent plant being sold to Novo

Reuters

Tue, 02/6/24 - 11:36 pm

drug manufacturing

Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains

Fierce Pharma

Tue, 02/6/24 - 09:33 am

Novo Holdings acquires Catalent in $16.5B deal, aiming to boost Wegovy production as demand soars

Medical Marketing and Media

Mon, 02/5/24 - 11:06 pm

drug manufacturing

Could Novo, Lilly become first trillion-dollar healthcare companies?

Pharma Voice

Mon, 02/5/24 - 10:30 am

Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

CNBC

Mon, 02/5/24 - 10:10 am

drug manufacturing

Pages